(Q36674049)

15 August 2017

Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass (English)

1 reference

15 August 2017

Richard G Moore

1

1 reference

15 August 2017

M Craig Miller

2

1 reference

15 August 2017

Paul Disilvestro

3

1 reference

15 August 2017

Lisa M Landrum

4

1 reference

15 August 2017

Walter Gajewski

5

1 reference

15 August 2017

John J Ball

6

1 reference

15 August 2017

Steven J Skates

7

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 August 2011

1 reference

Obstetrics and Gynecology

15 August 2017

1 reference

15 August 2017

118

1 reference

15 August 2017

2 Pt 1

1 reference

15 August 2017

280-288

1 reference

Comparison of a novel multiple marker assay vs the Risk of Malignancy Index for the prediction of epithelial ovarian cancer in patients with a pelvic mass

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

A novel multiple marker bioassay utilizing HE4 and CA125 for the prediction of ovarian cancer in patients with a pelvic mass

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Utility of a novel serum tumor biomarker HE4 in patients with endometrioid adenocarcinoma of the uterus

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Comprehensive analysis of HE4 expression in normal and malignant human tissues

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Who should operate on patients with ovarian cancer? An evidence-based review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

ACOG Committee Opinion: number 280, December 2002. The role of the generalist obstetrician-gynecologist in the early detection of ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Large-scale serial analysis of gene expression reveals genes differentially expressed in ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Elevation of multiple serum markers in patients with stage I ovarian cancer.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Evaluation of the accuracy of serum human epididymis protein 4 in combination with CA125 for detecting ovarian cancer: a prospective case-control study in a Korean population.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

The ROMA (Risk of Ovarian Malignancy Algorithm) for estimating the risk of epithelial ovarian cancer in women presenting with pelvic mass: is it really useful?

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Quality of care in advanced ovarian cancer: the importance of provider specialty

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Predictors of comprehensive surgical treatment in patients with ovarian cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3594110

Guidelines for referral to a gynecologic oncologist: rationale and benefits. The Society of Gynecologic Oncologists

20 September 2018

1 reference

12 December 2020

Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma

1 reference

12 December 2020

Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients

1 reference

12 December 2020

Improved short-term survival for advanced ovarian, tubal, and peritoneal cancer patients operated at teaching hospitals

1 reference

12 December 2020

Specialized and high-volume care leads to better outcomes of ovarian cancer treatment in the Netherlands

1 reference

12 December 2020

10.1097/AOG.0B013E318224FCE2

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

1 reference